Your browser doesn't support javascript.
loading
Inhibition of BRD4 Attenuates ER Stress-induced Renal Ischemic-Reperfusion Injury.
Diaz-Bulnes, Paula; Rodríguez, Ramon M; Banon-Maneus, Elisenda; Saiz, María Laura; Bernet, Cristian Ruiz; Corte-Iglesias, Viviana; Ramirez-Bajo, Maria Jose; Lazo-Rodriguez, Marta; Tamargo-Gómez, Isaac; Rodrigues-Diez, Raúl R; Sanz, Ana B; Diaz-Corte, Carmen; Ruiz-Ortega, Marta; Diekmann, Fritz; Aransay, Ana M; Lopez-Larrea, Carlos; Suarez-Alvarez, Beatriz.
Affiliation
  • Diaz-Bulnes P; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Rodríguez RM; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Banon-Maneus E; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Saiz ML; Lipids in Human Pathology, Health Research Institute of the Balearic Islands (IdISBa), Research Unit, University Hospital Son Espases, 07120 Palma, Spain.
  • Bernet CR; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Corte-Iglesias V; Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Ramirez-Bajo MJ; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Lazo-Rodriguez M; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Tamargo-Gómez I; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Rodrigues-Diez RR; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Sanz AB; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
  • Diaz-Corte C; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Ruiz-Ortega M; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Diekmann F; Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Aransay AM; Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Lopez-Larrea C; Autophagy and Metabolism Laboratory, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Suarez-Alvarez B; Translational Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Int J Biol Sci ; 20(5): 1547-1562, 2024.
Article in En | MEDLINE | ID: mdl-38481808
ABSTRACT
Renal ischemia-reperfusion injury (IRI) leads to endoplasmic reticulum (ER) stress, thereby initiating the unfolded protein response (UPR). When sustained, this response may trigger the inflammation and tubular cell death that acts to aggravate the damage. Here, we show that knockdown of the BET epigenetic reader BRD4 reduces the expression of ATF4 and XBP1 transcription factors under ER stress activation. BRD4 is recruited to the promoter of these highly acetylated genes, initiating gene transcription. Administration of the BET protein inhibitor, JQ1, one hour after renal damage induced by bilateral IRI, reveals reduced expression of ATF4 and XBP1 genes, low KIM-1 and NGAL levels and recovery of the serum creatinine and blood urea nitrogen levels. To determine the molecular pathways regulated by ATF4 and XBP1, we performed stable knockout of both transcription factors using CRISPR-Cas9 and RNA sequencing. The pathways triggered under ER stress were mainly XBP1-dependent, associated with an adaptive UPR, and partially regulated by JQ1. Meanwhile, treatment with JQ1 downmodulated most of the pathways regulated by ATF4 and related to the pathological processes during exacerbated UPR activation. Thus, BRD4 inhibition could be useful for curbing the maladaptive UPR activation mechanisms, thereby ameliorating the progression of renal disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Biol Sci / International journal of biological sciences Journal subject: BIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Biol Sci / International journal of biological sciences Journal subject: BIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: Australia